DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Impact of Asthma Treatments on Daily Activities

Information source: Ovation Research Group
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Asthma; Allergies

Phase: N/A

Status: Recruiting

Sponsored by: Ovation Research Group

Official(s) and/or principal investigator(s):
Susan D Mathias, MPH, Principal Investigator, Affiliation: Ovation Research Group

Overall contact:
Nita Ngo, MPH, Phone: 888.631.9167, Email: asthmastudy@ovation.org

Summary

The primary objective of this web-based, cross-sectional study is to assess and compare the ability to sleep, work or go to school, and to participate in leisure activities among subjects who are receiving Xolair treatment and subjects who were eligible to receive Xolair, but instead have been using Advair for at least 1 year.

Clinical Details

Official title: Study on Asthma Treatments on Daily Activities as Reported by Patients (STAR)

Study design: Observational Model: Defined Population, Time Perspective: Cross-Sectional

Eligibility

Minimum age: 18 Years. Maximum age: 55 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Have asthma and allergies

- Currently taking Xolair® or Advair®

- Started Xolair® treatment within the last 4 to 12 months OR have been taking Advair®

for at least 12 months

- Between 18 and 55 years of age

- A non-smoker for at least 6 months

- Have internet access

Locations and Contacts

Nita Ngo, MPH, Phone: 888.631.9167, Email: asthmastudy@ovation.org

Ovation Research Group, San Francisco, California 94105, United States; Recruiting
Susan D Mathias, MPH, Principal Investigator
Additional Information

Starting date: June 2006
Last updated: July 5, 2006

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017